Selank shows a sigmoidal dose-response curve with threshold effects around 100mcg, optimal anxiolytic activity at 300-600mcg, and plateau above 1000mcg. The therapeutic window is wide with minimal adverse effects across the entire dose range.
Dose-ranging studies establish 300-600mcg as the sweet spot balancing efficacy and duration for most users.